comparemela.com

Pharming N : Group provides update on ongoing regulatory review of leniolisib for the treatment of APDS in the European Union - Form 6-K

Pharming N : Group provides update on ongoing regulatory review of leniolisib for the treatment of APDS in the European Union - Form 6-K

marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Netherlands ,Israel ,United Kingdom ,Canada ,Amsterdam ,Noord Holland ,United States ,London ,City Of ,Australia ,Washington ,South Korea ,Japan ,America ,Christina Renfroe ,Michael Levitan ,Linkedin ,Lifespring Life Sciences Communication ,Pharming Groupnv ,Vp Investor Relations Corporate Communications ,Commission File Number ,Nasdaq ,Exchange Commission ,Pharming Group ,Committee For Medicinal Products Human Use ,Ad Hoc Expert Group ,Securities Exchange ,European Medicines Agency ,Drug Administration ,European Union ,File Number ,Exact Name ,Its Charter ,Regulationst Rule ,Securities Exchange Act ,Sijmen De Vries ,Marketing Authorisation Application ,Medicinal Products ,Human Use ,Outstanding Issues ,Chief Executive Officer ,Activated Phosphoinositide ,European Economic Area ,North America ,Middle East ,Annual Report ,Allergy Clin ,Rev Allergy ,Allergy Clin Immunol ,Spring Life Sciences Communication ,

comparemela.com © 2020. All Rights Reserved.